Lukang Biochemical (002868.SZ) announced its first half results, turning a loss into a profit of 7.316 million yuan

According to the Zhitong Finance App, Lukang Biochemical (002868.SZ) released its 2026 semi-annual report. During the reporting period, the company achieved revenue of 248 million yuan, a year-on-year decrease of 15.70%. Achieved net profit of 7.316 million yuan attributable to shareholders of listed companies. Achieve net profit of 9.8505 million yuan, which is attributable to shareholders of listed companies after deducting non-recurring profit and loss. Basic earnings per share were $0.0471.

The main reasons are: 1. In 2025, the company successfully divested its photovoltaic film subsidiary, which had deep losses in the year; 2. The company's veterinary medicine business achieved rapid revenue growth, reduced operating costs, and improved economic efficiency through technology and channel development and fine management.